Illumina, Inc. (ILMN) Stake Decreased by Cedar Capital LLC

Cedar Capital LLC decreased its position in shares of Illumina, Inc. (NASDAQ:ILMN) by 4.1% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 962 shares of the life sciences company’s stock after selling 41 shares during the period. Cedar Capital LLC’s holdings in Illumina were worth $299,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Proficio Capital Partners LLC increased its holdings in shares of Illumina by 61.7% in the fourth quarter. Proficio Capital Partners LLC now owns 97 shares of the life sciences company’s stock valued at $29,000 after purchasing an additional 37 shares in the last quarter. Colony Group LLC increased its holdings in shares of Illumina by 3.3% in the fourth quarter. Colony Group LLC now owns 1,172 shares of the life sciences company’s stock valued at $352,000 after purchasing an additional 37 shares in the last quarter. Massmutual Trust Co. FSB ADV increased its holdings in shares of Illumina by 83.0% in the fourth quarter. Massmutual Trust Co. FSB ADV now owns 86 shares of the life sciences company’s stock valued at $26,000 after purchasing an additional 39 shares in the last quarter. Sage Capital Advisors llc increased its holdings in shares of Illumina by 0.7% in the first quarter. Sage Capital Advisors llc now owns 5,887 shares of the life sciences company’s stock valued at $1,829,000 after purchasing an additional 40 shares in the last quarter. Finally, Sterling Investment Advisors Ltd. increased its holdings in shares of Illumina by 2.0% in the first quarter. Sterling Investment Advisors Ltd. now owns 2,090 shares of the life sciences company’s stock valued at $649,000 after purchasing an additional 40 shares in the last quarter. 90.80% of the stock is owned by institutional investors.

A number of brokerages recently weighed in on ILMN. BidaskClub lowered shares of Illumina from a “buy” rating to a “hold” rating in a report on Tuesday, April 30th. Zacks Investment Research raised shares of Illumina from a “hold” rating to a “buy” rating and set a $355.00 price target for the company in a report on Tuesday, April 2nd. OTR Global lowered shares of Illumina to a “positive” rating in a report on Tuesday, April 2nd. Bank of America reissued a “buy” rating and issued a $355.00 price target on shares of Illumina in a report on Wednesday, January 30th. Finally, Deutsche Bank lowered shares of Illumina from a “buy” rating to a “hold” rating and set a $296.53 price target for the company. in a report on Friday, January 25th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Illumina currently has an average rating of “Buy” and an average target price of $353.58.

In related news, SVP Mostafa Ronaghi sold 10,000 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $305.49, for a total value of $3,054,900.00. Following the sale, the senior vice president now directly owns 87,414 shares of the company’s stock, valued at approximately $26,704,102.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jay T. Flatley sold 3,300 shares of the business’s stock in a transaction on Wednesday, February 27th. The shares were sold at an average price of $300.00, for a total transaction of $990,000.00. Following the completion of the sale, the director now directly owns 341,568 shares in the company, valued at $102,470,400. The disclosure for this sale can be found here. Insiders sold a total of 50,329 shares of company stock worth $15,648,675 over the last ninety days. 0.38% of the stock is currently owned by insiders.

ILMN opened at $309.85 on Friday. The firm has a market capitalization of $45.07 billion, a P/E ratio of 54.17, a P/E/G ratio of 2.13 and a beta of 1.15. Illumina, Inc. has a 12 month low of $261.61 and a 12 month high of $372.61. The company has a current ratio of 3.66, a quick ratio of 3.33 and a debt-to-equity ratio of 0.27.

Illumina (NASDAQ:ILMN) last posted its quarterly earnings data on Thursday, April 25th. The life sciences company reported $1.60 EPS for the quarter, beating the consensus estimate of $1.34 by $0.26. The business had revenue of $846.00 million for the quarter, compared to analysts’ expectations of $838.70 million. Illumina had a net margin of 25.06% and a return on equity of 23.49%. The firm’s revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.45 EPS. As a group, equities analysts forecast that Illumina, Inc. will post 6.68 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Illumina, Inc. (ILMN) Stake Decreased by Cedar Capital LLC” was first published by Stock Observer and is owned by of Stock Observer. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.thestockobserver.com/2019/05/17/illumina-inc-ilmn-stake-decreased-by-cedar-capital-llc.html.

Illumina Company Profile

Illumina, Inc provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as enables the detection of known genetic markers on a single array.

See Also: What does the Dow Jones Industrial Average (DJIA) measure?

Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with MarketBeat.com's FREE daily email newsletter.